Brief: PharmaSGP Holding Outlook FY Revenue EUR 122-128 Million
15/04/2025 06:31
Apr 15 (Reuters) - PharmaSGP Holding outlook FY adjusted EBITDA EUR 37-39 million.
Recent news on PharmaSGP Holding SE
See all newsBrief: PharmaSGP Holding Outlook FY Revenue EUR 132-138 Million
Brief: PharmaSGP Holding Outlook FY Adjusted EBITDA EUR 37-39 Million
Brief: PharmaSGP Holding Q1 Adjusted EBITDA EUR 9.2 Million
Brief: PharmaSGP Holding Outlook FY Revenue EUR 122-128 Million
Brief: PharmaSGP Holding 9M Adjusted EBITDA EUR 27 Million